Kiniksa Pharmaceuticals, Ltd.KNSANASDAQ
Loading
Pre-tax earnings
3Y CAGR
+100.5%/yr
Annual compound
Percentile
P100
Near historical high
vs 3Y Ago
8.1x
Strong expansion
Streak
1 yr
Consecutive growthExpanding
| Period | Value | YoY Change |
|---|---|---|
| TTM | $88.87M | +345.8% |
| 2024 | $-36.15M | -117.1% |
| 2023 | $-16.65M | -251.0% |
| 2022 | $11.03M | +107.0% |
| 2021 | $-156.54M | -0.2% |
| 2020 | $-156.23M | +4.7% |
| 2019 | $-163.91M | -58.5% |
| 2018 | $-103.44M | -59.5% |
| 2017 | $-64.87M | -171.0% |
| 2016 | $-23.94M | - |